Tony Sun
Vorstandsvorsitzender bei XRad Therapeutics, Inc.
Vermögen: 4 Mio $ am 31.05.2024
Profil
Anthony Y.
Sun is currently the Chief Executive Officer & Director at Kalyra Pharmaceuticals, Inc., President, Chief Executive Officer & Director at XRad Therapeutics, Inc., Chairman at Zentera Therapeutics (Shanghai) Co., Ltd., Director at Immusoft Corp., Executive Director at Zeno Pharmaceuticals, Inc., and Director at Alloy Therapeutics LLC.
Previously, he served as the Executive Chairman, President & CEO at Zentalis Pharmaceuticals, Inc. from 2014 to 2022.
He was also a Director at MAP Pharmaceuticals LLC, Paratek Pharmaceuticals, Inc., CeNeRx BioPharma, Inc., Dynova Laboratories, Inc., Senex Biotechnology, Inc., and RetroSense Therapeutics LLC.
He served as an Independent Director at Versartis, Inc. from 2013 to 2018 and at Eyenovia, Inc. from 2018 to 2022.
Additionally, he was a Partner at Aisling Capital LLC from 2010 to 2015.
Dr. Sun received his undergraduate degree from Cornell University, his MBA from The Wharton School of the University of Pennsylvania, and his doctorate from Temple University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.04.2023 | 360 542 ( 0,51% ) | 4 Mio $ | 31.05.2024 |
Aktive Positionen von Tony Sun
| Unternehmen | Position | Beginn |
|---|---|---|
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 05.01.2018 |
Zeno Pharmaceuticals, Inc.
 Zeno Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Zentalis Pharmaceuticals, Inc., Zeno Pharmaceuticals, Inc. operates as a pharmaceutical company. The company is based in San Diego, CA. | Direktor/Vorstandsmitglied | - |
XRad Therapeutics, Inc.
 XRad Therapeutics, Inc. XRad Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in New York, NY. | Vorstandsvorsitzender | - |
Zentera Therapeutics (Shanghai) Co., Ltd.
 Zentera Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Zentera Therapeutics (Shanghai) Co., Ltd. is a biopharmaceutical company based in Shanghai, China. The Chinese company develops molecule therapeutics that target cancers. | Vorsitzender | - |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Vorstandsvorsitzender | - |
Alloy Therapeutics LLC
 Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Tony Sun
| Unternehmen | Position | Ende |
|---|---|---|
| EYENOVIA, INC. | Direktor/Vorstandsmitglied | 16.06.2022 |
| ZENTALIS PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 10.05.2022 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Direktor/Vorstandsmitglied | 12.10.2018 |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Tony Sun
| Temple University School of Medicine | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Cornell University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EYENOVIA, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 15 |
|---|---|
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Finance |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Health Technology |
Dynova Laboratories, Inc.
 Dynova Laboratories, Inc. Food RetailRetail Trade Dynova Laboratories, Inc. operates as a consumer health products company with deep sales and marketing expertise. It focuses on acquiring and developing natural supplements/OTC products. The company identifies brands, companies, and technologies for licensing or acquisition; and provides clinical, marketing, packaging, and sales support for dietary or natural supplements category. Dynova Laboratories was founded in 2006 and is headquartered in Parsippany, NJ. | Retail Trade |
CeNeRx BioPharma, Inc.
 CeNeRx BioPharma, Inc. Pharmaceuticals: MajorHealth Technology CeNeRx BioPharma, Inc. was manufactured pharmaceutical products. The company was founded in October 2005 by James Free, Barry Brand, and Mark J. Baric and was headquartered in Cary, NC. | Health Technology |
HerbalScience, Inc.
 HerbalScience, Inc. Household/Personal CareConsumer Non-Durables HerbalScience, Inc. manufactures and supplies health and wellness products. The private company is based in New Albany, OH. | Consumer Non-Durables |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Health Services |
RetroSense Therapeutics LLC
 RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Health Technology |
Senex Biotechnology, Inc.
 Senex Biotechnology, Inc. BiotechnologyHealth Technology Senex Biotechnology, Inc. is a drug discovery and development company focused on oncology therapeutics. The company was founded by Igor B. Roninson and is headquartered in Columbia, SC. | Health Technology |
Zeno Pharmaceuticals, Inc.
Zeno Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Zentalis Pharmaceuticals, Inc., Zeno Pharmaceuticals, Inc. operates as a pharmaceutical company. The company is based in San Diego, CA. | Health Technology |
XRad Therapeutics, Inc.
XRad Therapeutics, Inc. XRad Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in New York, NY. | |
Zentera Therapeutics (Shanghai) Co., Ltd.
Zentera Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Zentera Therapeutics (Shanghai) Co., Ltd. is a biopharmaceutical company based in Shanghai, China. The Chinese company develops molecule therapeutics that target cancers. | Health Technology |
Kalyra Pharmaceuticals, Inc.
Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Health Technology |
Alloy Therapeutics LLC
Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Commercial Services |
